-
The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees
Authors: Van Coillie J, Pongracz T, Rahmöller J, et al.
Journal: EBioMedicine 2023
Application: ELISA
Request for Full-text
-
Acquisition of furin cleavage site and further SARS-CoV-2 evolution change the mechanisms of viral entry, infection spread, and cell signaling
Authors: Frolova, Elena I et al.
Journal: Journal of virology 2022
Application: Western blot
Request for Full-text
-
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
Authors: Tianyang Mao, Benjamin Israelow, Mario A. Peña-Hernández, et al.
Journal: RESEARCH 2022
Application: SARS-CoV-2–specific antibody measurements
Request for Full-text
-
mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
Authors: Jana Sophia Buhre, Tamas Pongracz, Inga Künsting,et al.
Journal: Frontiers in Immunology 2023
Application: ELISA
Request for Full-text
-
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations
Authors: Elizabeth M. Anderson,Shuk Hang Li,Moses Awofolaju,et al.
Journal: Cell Reports 2022
Application: ELISA
Request for Full-text
-
Guest edited collection serological study of SARS-CoV-2 antibodies in japanese cats using protein-A/G-based ELISA
Authors: Imanishi I, Asahina R, Hayashi S, et al.
Journal: BMC Veterinary Research 2022
Application: ELISA
Request for Full-text
-
Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection
Authors: AR Rappaport, SJ Hong, CD Scallan, et. al
Journal: Nature Communications 2022
Application: ELISA
Request for Full-text
-
BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2
Authors: RC Brewer, NS Ramadoss, LJ Lahey, et. al
Journal: Nature immunology 2022
Application: Generation of barcoded fluorescent antigen tetramers,ELISA
Request for Full-text
-
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
Authors: S Gandhi, J Klein, AJ Robertson et al.
Journal: Nature Communicatins 2022
Application: Specific-antibody measurements
Request for Full-text
-
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19
Authors: K Sacco, R Castagnoli, S Vakkilainen, et al.
Journal: Nature Medicine 2022
Application: Cell-based Assay
Request for Full-text
-
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
Authors: AR Crowley, H Natarajan, AP Hederman,et al.
Journal: eLife 2022
Application: Antibody Screening
Request for Full-text
-
Serological Study of SARS-CoV-2 Antibodies in Japanese Cats: Analysis of Risk Factors Among Cat Lifestyles
Authors: I Imanishi, R Asahina, S Hayashi, et al.
Journal: Research Square 2022
Application: ELISA
Request for Full-text
-
The Chimeric Adenovirus (Ad5/35) Expressing Engineered Spike Protein Confers Immunity against SARS-CoV-2 in Mice and Non-Human Primates
Authors: SP Shin, KS Shin, JM Lee, et al.
Journal: Vaccines 2022
Application: ELISA
Request for Full-text
-
Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2
Authors: Denninger V, Xu CK, Meisl G, et al.
Journal: ACS Infect Dis 2022
Application: ELISA
Request for Full-text
-
No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination
Authors: Lu-Culligan A, Tabachnikova A, Pérez-Then E, et al.
Journal: PLoS biology 2022
Application: ELISA
Request for Full-text
-
SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses
Authors: Shah, Masaud et al.
Journal: Comput Struct Biotechnol J 2022
Application: SPR
Request for Full-text
-
Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19
Authors: Ghazanfari, Davoud et al.
Journal: Biochem Biophys Res Commun 2022
Application: Cell-based assay
Request for Full-text
-
Recent Advances in Rapid and Highly Sensitive Detection of Proteins and Specific DNA Sequences Using a Magnetic Modulation Biosensing System
Authors: S Roth, M Margulis, A Danielli
Journal: Sensors 2022
Application: ELISA
Request for Full-text
-
Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics
Authors: RV House, TA Broge, TJ Suscovich, et al.
Journal: PLoS ONE 2022
Application: ELISA
Request for Full-text
-
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants
Authors: Haslwanter, Denise et al.
Journal: mBio 2021
Application: Binding Assay
Request for Full-text
-
Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis
Authors: Collins DP, Steer CJ.
Journal: Hepatic medicine : evidence and research 2021
Application: Cell-based assay
Request for Full-text
-
Validation of high-throughput, semiquantitative solid phase SARS coronavirus-2 serology assays in serum and dried blood spot matrices
Authors: Maritz, Leo et al.
Journal: Bioanalysis 2021
Application: ELISA
Request for Full-text
-
Delayed production of neutralizing antibodies correlates with fatal COVID-19
Authors: Lucas C, Klein J, Sundaram ME, et al.
Journal: Nature medicine 2021
Application: ELISA
Request for Full-text
-
Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms
Authors: Song E, Bartley CM, Chow RD, et al.
Journal: Cell reports. Medicine 2021
Application: ELISA
Request for Full-text
-
Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
Authors: Dong J, Huang B, Wang B, et al.
Journal: Scientific reports 2021
Application: ELISA
Request for Full-text
-
Prolonged evolution of the human B cell response to SARS-CoV-2 infection
Authors: Sakharkar M, Rappazzo CG, Wieland-Alter WF, et al.
Journal: Science immunology 2021
Application: Binding Assay
Request for Full-text
-
HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry
Authors: Wei C, Wan L, Yan Q, et al.
Journal: Nature metabolism 2020
Application: SPR & FACS & Confocal microscopy
Request for Full-text
-
Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19
Authors: Luetkens T, Metcalf R, Planelles V, et al.
Journal: Blood advances 2020
Application: ELISA
Request for Full-text
-
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Authors: Pierce CA, Preston-Hurlburt P, Dai Y, et al.
Journal: Sci Transl Med 2020
Application: ELISA
Request for Full-text
-
Binding of the SARS-CoV-2 Spike Protein to Glycans
Authors: Wei Hao, Bo Ma, Ziheng Li, et al
Journal: BioRxiv (preprint) 2020
Application: glycan microarray
Request for Full-text